GREGORY L. WEAVER - 17 Jun 2021 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
Chief Financial Officer
Signature
/s/ Ryan Barrett, Attorney-in-fact
Issuer symbol
ATAI
Transactions as of
17 Jun 2021
Net transactions value
$0
Form type
4
Filing time
22 Jun 2021, 16:20:55 UTC
Previous filing
18 May 2021
Next filing
24 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATAI Stock Option Award $0 +67,726 $0.000000 67,726 17 Jun 2021 Common Shares 67,726 $15.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the underlying shares on June 17, 2022, and the remaining vests in 36 equal monthly installments thereafter.